Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1

Journal of Neuroimmunology

Volumn 92, Issue 1-2, 1998, Pages 98-108

  Kennedy, Kevin J ^a   Strieter, Robert M ^b   Kunkel, Steven L ^b   Lukacs, Nicholas W ^b   Karpus, William J ^a  

^a Robert H Lurie C   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune encephalomyelitis; Central nervous system; Chemokines; Cytokines; Multiple sclerosis

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACUTE DISEASE; ANIMALS; ANTIBODIES; CHEMOKINE CCL2; CHEMOKINES; CHRONIC DISEASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED STRAINS; MONOCYTES; RANTES; RECURRENCE; SEVERITY OF ILLNESS INDEX; SPINAL CORD;

EID: 0032415886     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00187-8     Document Type: Article

References (44)

1. Arnason B.G. Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol. Clin. 1:1983;765-782.
2. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
3. Brosnan C.F., Bornstein M.B., Bloom B.R. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126:1981;614-620.
4. Carr M.W., Alon R., Springer T.A. The C-C chemokine MCP-1 differentially modulates the avidity of β1 and β2 integrins on T lymphocytes. Immunity. 4:1996;179-187.
5. 14C -labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis Lab. Invest. 63:1990;162-170.
6. Davatelis G., Tekamp-Olson P., Wolpe S.D., Hermsen K., Luedke C., Gallegos C., Coit D., Merryweather J., Cerami A. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokine properties. J. Exp. Med. 167:1988;1939-1944.
7. Glabinski A.R., Tani M., Strieter R.M., Tuohy V.K., Ransohoff R.M. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:1997;617-630.
8. Godiska R., Chantry D., Dietsch G.N., Gray P.W. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:1995;167-176.
9. Hartung H.P., Rieckmann P. Pathogenesis of immune-mediated demyelination in the CNS. J. Neural Transm. 104:1997;173-181. (Suppl. 50).
10. Hayashi M., Luo Y., Laning J., Strieter R.M., Dorf M.E. Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells. J. Neuroimmunol. 60:1995;143-150.
11. Hickey W.F., Gonatas N.K., Kimura H., Wilson D.B. Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J. Immunol. 131:1983;2805-2809.
12. Huitinga I., Van Rooijen N., de Groot C.J., Uitdehaag B.M., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172:1990;1025-1033.
13. Hulkower K., Brosnan C.F., Aquino D.A., Cammer W., Kulshrestha S., Guida M.P., Rapoport D.A., Berman J.W. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150:1993;2525-2533.
14. + Th1 but not Th2 cytokine responses. Int. Immunol. 6:1994;721-730.
15. Karpus W.J., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel S.L., Miller S.D. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:1995;5003-5010.
16. Kawai K., Kobayashi Y., Shiratori M., Sobue G., Tamatani T., Miyasaka M., Yoshikai Y. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats. Cell. Immunol. 171:1996;262-268.
17. Kobayashi Y., Kawai K., Honda H., Tomida S., Niimi N., Tamatani T., Miyasaka M., Yoshikai Y. Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis. Cell. Immunol. 164:1995;295-305.
18. Kuchroo V.K., Sobel R.A., Laning J.C., Martin C.A., Greenfield E., Dorf M.E., Lees M.B. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor Vβ usage. J. Immunol. 148:1992;3776-3782.
19. Kuchroo V.K., Martin C.A., Greer J.M., Ju S.-T., Sobel R.A., Dorf M.E. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:1993;4371-4382.
20. Lou J., Dayer J.M., Grau G.E., Burger D. Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. Eur. J. Immunol. 26:1996;3107-3113.
21. Lukacs N.W., Kunkel S.L., Strieter R.M., Warmington K., Chensue S.W. The role of macrophage inflammatory protein 1α in Shistosoma mansoni egg-induced granulomatous inflammation. J. Exp. Med. 177:1993;1551-1559.
22. Lukacs N.W., Chensue S.W., Smith R.E., Strieter R.M., Warmington K., Wilke C., Kunkel S.L. Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts. Am. J. Pathol. 144:1994;711-718.
23. Lukacs N.W., Strieter R.M., Elner V.M., Evanoff H.L., Burdick M., Kunkell S.L. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1α during monocyte-endothelial cell interactions. Blood. 83:1994;1174-1178.
24. Lukacs N.W., Strieter R.M., Elner V., Evanoff H.L., Burdick M.D., Kunkel S.L. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte endothelial cell interactions. Blood. 86:1995;2767-2773.
25. Lukacs N.W., Strieter R.M., Warmington K., Lincoln P., Chensue S.W., Kunkel S.L. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J. Immunol. 158:1997;4398-4404.
26. McRae B.L., Kennedy M.K., Tan L.J., Dal Canto M.C., Miller S.D. Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38:1992;229-240.
27. Morrissey S.P., Deichmann R., Syha J., Simonis C., Zettl U., Archelos J.J., Jung S., Stodal H., Lassmann H., Toyka K.V., Haase A., Hartung H.P. Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies. J. Neuroimmunol. 69:1996;85-93.
28. Oppenheim J.J., Zachariae C.O.C., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene intercrine cytokine family. Ann. Rev. Immunol. 9:1991;617-648.
29. + T cell-mediated pathology. J. Immunol. 156:1996;4050-4058.
30. Powell M.B., Mitchell D., Lederman J., Buckmeier J., Zamvil S.S., Graham M., Ruddle N.H., Steinman L. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:1990;539-544.
31. Ransohoff R., Hamilton T., Tani M., Stoler M., Shick H., Major J., Estes M., Thomas D., Tuohy V.K. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:1993;592-600.
32. Rosenman S.J., Shrikant P., Dubb L., Benveniste E.N., Ransohoff R.M. Cytokine-induced expression of vascular adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154:1995;1888-1899.
33. Schall T.J. Biology of the RANTES/SIS cytokine family. Cytokine. 3:1991;165-183.
34. Shrikant P., Chung I.Y., Ballestas M.E., Benveniste E.N. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-gamma in astrocytes. J. Neuroimmunol. 51:1994;209-220.
35. Sobel R.A., Tuohy V.K., Lu Z.J., Laursen R.A., Lees M.B. Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein. J. Neuropathol. Exp. Neurol. 49:1990;468-479.
36. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
37. Strieter R.M., Kunkel S.L., Burdick M.D., Lincoln D.M., Walz A. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol. Invest. 21:1992;589-596.
38. + T cells in response to MIP-1α and MIP-1β Science. 260:1993;355-358.
39. Tuohy V.K., Sobel R.A., Lu Z., Laursen R.A., Lees M.B. Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J. Neuroimmunol. 39:1992;67-74.
40. Wekerle H. Immunopathogenesis of multiple sclerosis. Acta Neurologica. 13:1991;197-204.
41. Whitham R.H., Bourdette D.N., Hashim G.A., Herndon R.M., Ilg R.C., Vandenbark A.A., Offner H. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 146:1991;101-107.
42. Willenborg D.O., Staykova M.A., Miyasaka M. Short-term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis - treatment abrogates autoimmune disease but not autoimmunity. J. Immunol. 157:1996;1973-1980.
43. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature. 356:1992;63-66.
44. Zar, J.H., 1984. Biostatistical Analysis, 2nd edn. Prentice-Hall, Englewood Cliffs, NJ.